Single-cell transcriptomics identifies neural fate disruption and glial reprogramming caused by <i>RARS2</i> deficiency

Background Pontocerebellar hypoplasia type 6 (PCH6) is caused by biallelic pathogenic variants in RARS2 , encoding mitochondrial arginyl-tRNA synthetase. Although mitochondrial dysfunction is a recognised feature, how RARS2 deficiency disrupts neural lineage development remains unclear. Methods We generated rars2 -deficient zebrafish using the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system and performed single-cell RNA sequencing (scRNA-seq) at 48 hours postfertilisation, complemented by immunofluorescence, in situ hybridisation, behavioural assays and ultrastructural analyses. Neural lineage composition, developmental trajectories, intercellular communication and transcriptional programmes were systematically examined. Results rars2 −/− zebrafish displayed impaired survival, locomotor deficits, early mitochondrial ultrastructural damage and marked disruption of neurogenesis. scRNA-seq revealed reduced neuronal populations and expansion of neural progenitor and glial-like cells. Key neurogenic regulators ( neurod4 , her6 and pou3f1 ) were downregulated, whereas glial and stress-associated markers ( hmgb1a, fabp7a and foxp1b ) were upregulated. Developmental pathways including Notch and non-canonical Wnt were attenuated while extracellular matrix (ECM), adhesion and inflammatory programmes were activated. Additional trajectory-based analyses supported dysregulated lineage progression characterised by glial programme activation and impaired maintenance of neurogenic differentiation. Conclusion RARS2 deficiency disrupts mitochondrial integrity and reprograms neural lineage development through coordinated suppression of neurogenic transcriptional networks and activation of glial/ECM programmes. These findings provide mechanistic insight into loss-of-function RARS2 deficiency and highlight candidate molecular pathways for future therapeutic investigation.

Authors

Institutions

Publication Details

Journal
Journal of Medical Genetics
Published
2026-07-30
DOI
https://doi.org/10.1136/jmg-2025-111413
Primary Topic
Fetal and Pediatric Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-cell transcriptomics identifies neural fate disruption and glial reprogramming caused by RARS2 deficiency

Shanling Liu, Huaqin Sun, Cong Zhou, Jing Wang et al.
Journal of Medical Genetics
Fetal and Pediatric Neurological Disorders
article

Single-cell transcriptomics identifies neural fate disruption and glial reprogramming caused by RARS2 deficiency

Shanling Liu, Huaqin Sun, Cong Zhou, Jing Wang, Xing Wei, Yanyun Wang, Zhaoyi Chen, Lin Zhang, Bin Zhou
article en

Abstract

Background Pontocerebellar hypoplasia type 6 (PCH6) is caused by biallelic pathogenic variants in RARS2 , encoding mitochondrial arginyl-tRNA synthetase. Although mitochondrial dysfunction is a recognised feature, how RARS2 deficiency disrupts neural lineage development remains unclear. Methods We generated rars2 -deficient zebrafish using the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system and performed single-cell RNA sequencing (scRNA-seq) at 48 hours postfertilisation, complemented by immunofluorescence, in situ hybridisation, behavioural assays and ultrastructural analyses. Neural lineage composition, developmental trajectories, intercellular communication and transcriptional programmes were systematically examined. Results rars2 −/− zebrafish displayed impaired survival, locomotor deficits, early mitochondrial ultrastructural damage and marked disruption of neurogenesis. scRNA-seq revealed reduced neuronal populations and expansion of neural progenitor and glial-like cells. Key neurogenic regulators ( neurod4 , her6 and pou3f1 ) were downregulated, whereas glial and stress-associated markers ( hmgb1a, fabp7a and foxp1b ) were upregulated. Developmental pathways including Notch and non-canonical Wnt were attenuated while extracellular matrix (ECM), adhesion and inflammatory programmes were activated. Additional trajectory-based analyses supported dysregulated lineage progression characterised by glial programme activation and impaired maintenance of neurogenic differentiation. Conclusion RARS2 deficiency disrupts mitochondrial integrity and reprograms neural lineage development through coordinated suppression of neurogenic transcriptional networks and activation of glial/ECM programmes. These findings provide mechanistic insight into loss-of-function RARS2 deficiency and highlight candidate molecular pathways for future therapeutic investigation.

Journal of Medical Genetics
Sichuan University (CN), University of Massachusetts Amherst (US), West China Second University Hospital of Sichuan University (CN), University of Hong Kong (HK)
National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Fundamental Research Funds for the Central Universities
Openalex Percentile: Top 6%
Fetal and Pediatric Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.